GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Indegene Ltd (NSE:INDGN) » Definitions » ROE % Adjusted to Book Value

Indegene (NSE:INDGN) ROE % Adjusted to Book Value : 0.00% (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Indegene ROE % Adjusted to Book Value?

Indegene's ROE % for the quarter that ended in Dec. 2024 was 18.59%. Indegene's PB Ratio for the quarter that ended in Dec. 2024 was N/A. Indegene's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was N/A.

Indegene ROE % Adjusted to Book Value Historical Data

The historical data trend for Indegene's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Indegene ROE % Adjusted to Book Value Chart

Indegene Annual Data
Trend Mar21 Mar22 Mar23 Mar24
ROE % Adjusted to Book Value
- - - -

Indegene Quarterly Data
Mar21 Mar22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 2.21 -

Competitive Comparison of Indegene's ROE % Adjusted to Book Value

For the Health Information Services subindustry, Indegene's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Indegene's ROE % Adjusted to Book Value Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Indegene's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Indegene's ROE % Adjusted to Book Value falls into.


;
;

Indegene ROE % Adjusted to Book Value Calculation

Indegene's ROE % Adjusted to Book Value for the fiscal year that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=27.01% / N/A
=N/A

Indegene's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=18.59% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Indegene ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Indegene's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Indegene Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Indegene Ltd (NSE:INDGN) » Definitions » ROE % Adjusted to Book Value
Comparable Companies
NSE:SAGILITY NSE:IKS BOM:538837 NSE:DHTL VEEV GEHC ASX:PME DOCS TEM TSE:2413 HQY WAY SZSE:300253 HKSE:02228 HKSE:02587 BTSG PRVA HKSE:01833 HKSE:02506 PINC
Traded in Other Exchanges
544172:India
Address
Outer Ring Road, Aspen Block G4, 3rd Floor, Manyata Embassy Business Park, Nagawara, Bengaluru, KA, IND, 560045
Website
https://www.indegene.com
Indegene Ltd provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech, and medical devices companies, that assist them with drug development and clinical trials, regulatory submissions, pharmacovigilance and complaints management, and the sales and marketing of their products. Its portfolio of solutions covers all aspects of commercial, medical, regulatory, and R&D operations of life sciences companies. The company segment includes Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation, and Others. Key revenue is generated from the Omnichannel Activation segment.

Indegene Headlines

No Headlines